Literature DB >> 4088306

Second cancer following cancer of the female breast in Denmark, 1943-80.

M Ewertz, H T Mouridsen.   

Abstract

The risk of a person developing a second primary cancer was evaluated in approximately 55,000 women diagnosed with breast cancer in Denmark between 1943 and 1980. Excluding second cancers of the contralateral breast, 2,480 new cancers were observed compared with 2,398 expected (relative risk = 1.03; 95% CI = 0.99-1.08). Breast cancer patients followed for 10 years or more showed a significant 13% excess of all second primary tumors. Significant excesses of cancers of the lung, bone, and connective tissue were observed. Although some misclassification of metastases may have occurred, the risk of second cancers at these sites (as well as the salivary gland and esophagus) increased significantly with time and was especially high among women followed for 10 years or more. These observations suggest that radiation, as a part of the initial treatment, may have been involved. Radiation or chemotherapy, or both, may also have influenced the risk of acute nonlymphocytic leukemia (51 cases observed vs. 20.7 expected), which remained significantly elevated after the first year of follow-up. Common risk factors, related to reproductive experience and nutrition, may have contributed to the excess risk of cancers of the ovary and colon. On the other hand, an anticipated excess of cancer of the corpus uteri was not found, although cancer of the uterus not otherwise specified was significantly increased. Significant deficits were observed for second cancers of the liver and biliary tract, due perhaps to underreporting or conservative coding practices, or both. A significant excess of malignant melanoma was not easily explained but might indicate a common hormonal etiology with breast cancer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4088306

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  21 in total

Review 1.  Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies.

Authors:  Issa J Dahabreh; Thomas A Trikalinos; Jessica K Paulus
Journal:  Lung Cancer       Date:  2011-12-09       Impact factor: 5.705

2.  Age at diagnosis and multiple primary cancers of the breast and ovary.

Authors:  P J Suris-Swartz; J M Schildkraut; M F Vine; I Hertz-Picciotto
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Other malignancies in patients with breast cancer: a single institute experience.

Authors:  Erkan Dogan; Sercan Aksoy; Omer Dizdar; Didem S Dede; Cagatay Arslan; Yavuz Ozisik; Kadri Altundag
Journal:  Med Oncol       Date:  2010-12       Impact factor: 3.064

Review 4.  Skin cancer risk in BRCA1/2 mutation carriers.

Authors:  P V Gumaste; L A Penn; R M Cymerman; T Kirchhoff; D Polsky; B McLellan
Journal:  Br J Dermatol       Date:  2015-04-29       Impact factor: 9.302

Review 5.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

6.  Do chemo- and radiotherapy affect the DNA repair ability of lymphocytes?

Authors:  E Kovacs; H Langemann; H Ludwig
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

7.  Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers.

Authors:  G C Kabat
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

8.  Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications.

Authors:  T Pal; N Hamel; D Vesprini; K Sanders; M Mitchell; N Quercia; N Ng Cheong; A Murray; W Foulkes; S A Narod
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

9.  BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.

Authors:  Christian Monnerat; Agnès Chompret; Caroline Kannengiesser; Marie-Françoise Avril; Nicolas Janin; Alain Spatz; Jean-Marc Guinebretière; Catalin Marian; Michel Barrois; Françoise Boitier; Gilbert M Lenoir; Brigitte Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2007-07-12       Impact factor: 2.375

10.  Postirradiation sarcoma: clinicopathologic features and role of chemotherapy in the treatment strategy.

Authors:  Gaetan des Guetz; Alain Chapelier; Véronique Mosseri; Thierry Dorval; Bernard Asselain; Pierre Pouillart
Journal:  Sarcoma       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.